Stay updated on SNDX-5613 in R/R Leukemias: Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 in R/R Leukemias: Clinical Trial page.

Latest updates to the SNDX-5613 in R/R Leukemias: Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a new publication citation (Mol Cell Proteomics, 2026) and updated the page revision to v3.4.3; the prior citation was removed (v3.4.2).SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedPhase 2 expansion cohorts increased from 3 to 4 with the addition of Cohort 2D (HOX/MEIS upregulation leukemias, including KMT2Ar, NPM1m, and NUP98r) and the enrollment target is updated to 447. Key inclusion/exclusion criteria were added or revised (e.g., CNS prophylaxis allowed, concurrent cytoreductive therapies permitted, and other drug interactions) to reflect new eligibility and concomitant therapy guidelines.SummaryDifference1%

- Check32 days agoChange DetectedThe page shows a minor revision update from v3.4.1 to v3.4.2 with no observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedA new 2026 publication reference was added to Publications (Garcia MB et al., High-throughput proteomic profiling to evaluate differentiation syndrome with menin inhibition, Mol Cell Proteomics, 2026 Jan 30:101522, Online ahead of print) and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a glossary toggle and new metadata items (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); removed the older QC-related date, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check54 days agoChange DetectedThe 'Last Update Posted' entry changed from 'Estimated' (2025-11-07) to a concrete date (2025-11-10) in the Study Record Dates section.SummaryDifference0.1%

Stay in the know with updates to SNDX-5613 in R/R Leukemias: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 in R/R Leukemias: Clinical Trial page.